Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F ROUSSEL

Showing results (291-300 of 306) with videos related to

Pageof 31
Sort By:
Science Translational Medicine|January 21, 2021
Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastomaRaelene Endersby, Jacqueline Whitehouse, Allison Pribnow, et al.
Cancer Research|January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood CancersAdam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Cancer Research|March 20, 2019
Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus CarcinomaJun Wang, Diana M Merino, Nicholas Light, et al.
Neuro-Oncology Pediatrics|March 27, 2026
Targeting the p53 pathway to treat atypical teratoid rhabdoid tumorsAlaa Refaat, Hyekyung P Cho, Justin S Williams, et al.
The Journal of Clinical Investigation|June 17, 2024
Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical modelsJezabel Rodriguez-Blanco, April D Salvador, Robert K Suter, et al.
Cancer Research|July 12, 2020
Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP Jake Slavish, Liying Chi, Mi-Kyung Yun, et al.
Nature|December 15, 2010
Subtypes of medulloblastoma have distinct developmental originsPaul Gibson, Yiai Tong, Giles Robinson, et al.
Cancer Cell|September 3, 2019
Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and RelapseLiguo Zhang, Xuelian He, Xuezhao Liu, et al.
Neuro-Oncology|May 4, 2026
Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymomaSiri M Ippagunta, Amir Arabzade, Srinidhi Varadharajan, et al.
Cancer Cell|May 16, 2025
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic targetShiekh Tanveer Ahmad, Yiran Li, Jesus Garcia-Lopez, et al.
Pageof 31

Showing results (291-300 of 306) with videos related to

Sort By:
Pageof 31
Science Translational Medicine|January 21, 2021
Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastomaRaelene Endersby, Jacqueline Whitehouse, Allison Pribnow, et al.
Cancer Research|January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood CancersAdam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Cancer Research|March 20, 2019
Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus CarcinomaJun Wang, Diana M Merino, Nicholas Light, et al.
Neuro-Oncology Pediatrics|March 27, 2026
Targeting the p53 pathway to treat atypical teratoid rhabdoid tumorsAlaa Refaat, Hyekyung P Cho, Justin S Williams, et al.
The Journal of Clinical Investigation|June 17, 2024
Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical modelsJezabel Rodriguez-Blanco, April D Salvador, Robert K Suter, et al.
Cancer Research|July 12, 2020
Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP Jake Slavish, Liying Chi, Mi-Kyung Yun, et al.
Nature|December 15, 2010
Subtypes of medulloblastoma have distinct developmental originsPaul Gibson, Yiai Tong, Giles Robinson, et al.
Cancer Cell|September 3, 2019
Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and RelapseLiguo Zhang, Xuelian He, Xuezhao Liu, et al.
Neuro-Oncology|May 4, 2026
Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymomaSiri M Ippagunta, Amir Arabzade, Srinidhi Varadharajan, et al.
Cancer Cell|May 16, 2025
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic targetShiekh Tanveer Ahmad, Yiran Li, Jesus Garcia-Lopez, et al.
Pageof 31